English
Please Select Search Type
Please Enter Keywords
Search
Please Select Search Type
Please Enter Keywords
Search
English
Current Location:
Reports

Global Pharmaceutical CDMO Market Size, Competition Landscape and Supply Chain Research Report 2025

Published:2025-04-10
Pages:155
Tables and Figures:170
Report ID:WENKH000030
Report Format:
Delivery:48-72h
Select Type ：
Full Report
Competitive Landscape
Select Version ：
Single Users License：$ 3700
Buy Now
Request Sample
Custom Reports
Contact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, quoted and modified our original report catalog without authorization, and sold reports under our brand, which has seriously infringed our interests. Therefore, our company recommends that you contact the relevant phone number, email address or leave a message to purchase the report to prevent being deceived.
*All report contents displayed on this website are original to WENKH, and our company has the sole copyright. Any modification, reprinting or quoting in any form is prohibited without our prior written permission. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures
Full Report

Research Summary

A Pharmaceutical Contract Development and Manufacturing Organization (CDMO) is a specialized service provider that offers comprehensive support to pharmaceutical and biotechnology companies in the development, manufacturing, and commercialization of drug products. CDMOs serve as strategic partners, providing expertise and infrastructure for various stages of the drug development process, including formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. These organizations play a crucial role in the pharmaceutical industry by offering flexible and cost-effective solutions, enabling companies to outsource specific aspects of their drug development and manufacturing processes. Pharmaceutical CDMOs contribute to accelerating time-to-market, reducing development costs, and ensuring compliance with regulatory standards, allowing pharmaceutical companies to focus on research, innovation, and core competencies.

According to WENKH research statistics, the global Pharmaceutical CDMO market size will reach 172,804 Million USD in 2025 and is projected to reach 286,131 Million USD by 2032, with a CAGR of 7.47% (2025-2032). Among them, the Asia-Pacific Pharmaceutical CDMO market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.

The role of CDMOs in the global pharmaceutical ecosystem is becoming more strategic than ever, as drug developers increasingly outsource not just manufacturing, but also R&D, formulation design, and regulatory support. The push toward leaner operations and faster time-to-market has made CDMOs valuable partners in both early-stage development and late-phase commercialization. Companies are no longer looking for just capacity—they want technical agility, quality consistency, and innovation alignment. CDMOs that specialize in high-barrier technologies such as biologics, mRNA, and sterile injectables are gaining a competitive edge, especially as the pipeline of complex, niche therapies grows.

The application prospects for CDMO products are expanding in line with shifts in the global drug innovation landscape. Small and mid-sized biotech firms, often operating with limited internal infrastructure, are relying on CDMOs for integrated solutions—from process development to clinical trial material supply and commercial batch production. The rise of personalized medicine and precision therapies is further shaping demand for flexible, small-batch manufacturing capabilities. CDMOs that can scale quickly without compromising quality or regulatory compliance are becoming essential enablers of product launch success, particularly in fast-moving fields like oncology, rare diseases, and gene therapy. Global macro trends are also redefining how CDMO services are used. Governments are investing in localized production for national health security, while pharma companies are seeking supply chain redundancy after disruptions seen during the COVID-19 pandemic. This makes CDMOs with multi-region manufacturing footprints and digitalized operations increasingly attractive.

The global Pharmaceutical CDMO market is highly competitive, with key market players including Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi Biologics, Asymchem, Zhejiang Jiuzhou Pharmaceutical, Apeloa Pharmaceutical, Porton Pharma, Amatsigroup, Fujifilm Diosynth, Biotechnologies, PCI Pharma Services, Pfizer CentreOne, Samsung Biologics, AGC Biologics, Divi＇s Laboratories Ltd, Piramal Pharma Solutions, Syngene International Ltd, Aragen Life Sciences, Akums Drugs and Pharmaceuticals, IDT Australia, Mayne Pharma, BioCina, Southern RNA, PharmSky Research, etc. This report categorizes the competitive landscape of the global Pharmaceutical CDMO market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Pharmaceutical CDMO market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Pharmaceutical CDMO industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Pharmaceutical CDMO and their downstream application fields.

In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of Pharmaceutical CDMO in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Pharmaceutical CDMO market. By considering local policies, this report evaluates the market prospects of Pharmaceutical CDMO in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.

Companies Covered

Lonza

Catalent

Patheon (Thermo Fisher Scientific)

Aenova

Siegfried

Recipharm

Strides Shasun

Piramal

Metrics

AMRI

Famar

WuXi Biologics

Asymchem

Zhejiang Jiuzhou Pharmaceutical

Apeloa Pharmaceutical

Porton Pharma

Amatsigroup

Fujifilm Diosynth

Biotechnologies

PCI Pharma Services

Pfizer CentreOne

Samsung Biologics

AGC Biologics

Divi＇s Laboratories Ltd

Piramal Pharma Solutions

Syngene International Ltd

Aragen Life Sciences

Akums Drugs and Pharmaceuticals

IDT Australia

Mayne Pharma

BioCina

Southern RNA

PharmSky Research

Product Segment

Solid Formulation

Semi-solid Formulation

Liquid Formulation

Gas Formulation

Product Application

Chemical Pharmaceutical

Biopharmaceutical

Others


Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Pharmaceutical CDMO Industry Chain Analysis

Chapter 3: Global Pharmaceutical CDMO Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Pharmaceutical CDMO Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Pharmaceutical CDMO Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis

Chapter 7: North America Pharmaceutical CDMO Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 8: Europe Pharmaceutical CDMO Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 9: China Pharmaceutical CDMO Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 10: Asia Pacific (excluding China) Pharmaceutical CDMO Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 11: Latin America Pharmaceutical CDMO Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 12: Middle East and Africa Pharmaceutical CDMO Product Segment, Downstream Application, and Major Countries Market Size Analysis

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source


Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.

Table of Contents

1 Pharmaceutical CDMO Market Overview

   1.1 Product Definition Introduction

   1.2 Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis (2020-2032)

   1.3 Pharmaceutical CDMO Market Status and Development Prospects

       1.3.1 Pharmaceutical CDMO Market Status

       1.3.2 Pharmaceutical CDMO Industry Development Prospects

   1.4 Pharmaceutical CDMO Market Overview by Product Segment

       1.4.1 Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032

       1.4.2 Solid Formulation

       1.4.3 Semi-solid Formulation

       1.4.4 Liquid Formulation

       1.4.5 Gas Formulation

   1.5 Pharmaceutical CDMO Market Overview by Product Application

       1.5.1 Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032

       1.5.2 Chemical Pharmaceutical

       1.5.3 Biopharmaceutical

       1.5.4 Others

2 Pharmaceutical CDMO Industry Supply Chain Analysis

   2.1 Pharmaceutical CDMO Supply Chain

   2.2 Pharmaceutical CDMO Midstream Suppliers

   2.3 Pharmaceutical CDMO Downstream Customers

   2.4 Pharmaceutical CDMO Sales Channel Analysis

3 Pharmaceutical CDMO Market Environment Analysis

   3.1 Pharmaceutical CDMO Industry Policy Analysis

   3.2 Pharmaceutical CDMO Emerging Technology Trends in the Industry

   3.3 Pharmaceutical CDMO Restraining Factors Analysis

   3.4 Pharmaceutical CDMO Market Porter's Five Forces Analysis

       3.4.1 Competitive Rivalry

       3.4.2 Threat of New Entrants

       3.4.3 Bargaining Power of Suppliers

       3.4.4 Bargaining Power of Buyers

       3.4.5 Threat of Substitute Products or Services

4 Global Pharmaceutical CDMO Market Players Competition Landscape

   4.1 Global Pharmaceutical CDMO Market Revenue by Key Players (2021-2025)

   4.2 Global Pharmaceutical CDMO Market Position by Key Players

   4.3 Global Key Players Headquarter and Key Area Served

   4.4 Global Pharmaceutical CDMO Market Expansion and M&A Dynamic

5 In-depth Analysis of Key Players

   5.1 Lonza

       5.1.1 Lonza Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.1.2 Lonza Pharmaceutical CDMO Product Features

       5.1.3 Lonza Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.1.4 Lonza Pharmaceutical CDMO Revenue by Product Segment

       5.1.5 Lonza Pharmaceutical CDMO Revenue by Region

   5.2 Catalent

       5.2.1 Catalent Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.2.2 Catalent Pharmaceutical CDMO Product Features

       5.2.3 Catalent Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.2.4 Catalent Pharmaceutical CDMO Revenue by Product Segment

       5.2.5 Catalent Pharmaceutical CDMO Revenue by Region

   5.3 Patheon (Thermo Fisher Scientific)

       5.3.1 Patheon (Thermo Fisher Scientific) Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.3.2 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Product Features

       5.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Revenue by Product Segment

       5.3.5 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Revenue by Region

   5.4 Aenova

       5.4.1 Aenova Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.4.2 Aenova Pharmaceutical CDMO Product Features

       5.4.3 Aenova Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.4.4 Aenova Pharmaceutical CDMO Revenue by Product Segment

       5.4.5 Aenova Pharmaceutical CDMO Revenue by Region

   5.5 Siegfried

       5.5.1 Siegfried Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.5.2 Siegfried Pharmaceutical CDMO Product Features

       5.5.3 Siegfried Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.5.4 Siegfried Pharmaceutical CDMO Revenue by Product Segment

       5.5.5 Siegfried Pharmaceutical CDMO Revenue by Region

   5.6 Recipharm

       5.6.1 Recipharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.6.2 Recipharm Pharmaceutical CDMO Product Features

       5.6.3 Recipharm Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.6.4 Recipharm Pharmaceutical CDMO Revenue by Product Segment

       5.6.5 Recipharm Pharmaceutical CDMO Revenue by Region

   5.7 Strides Shasun

       5.7.1 Strides Shasun Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.7.2 Strides Shasun Pharmaceutical CDMO Product Features

       5.7.3 Strides Shasun Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.7.4 Strides Shasun Pharmaceutical CDMO Revenue by Product Segment

       5.7.5 Strides Shasun Pharmaceutical CDMO Revenue by Region

   5.8 Piramal

       5.8.1 Piramal Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.8.2 Piramal Pharmaceutical CDMO Product Features

       5.8.3 Piramal Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.8.4 Piramal Pharmaceutical CDMO Revenue by Product Segment

       5.8.5 Piramal Pharmaceutical CDMO Revenue by Region

   5.9 Metrics

       5.9.1 Metrics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.9.2 Metrics Pharmaceutical CDMO Product Features

       5.9.3 Metrics Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.9.4 Metrics Pharmaceutical CDMO Revenue by Product Segment

       5.9.5 Metrics Pharmaceutical CDMO Revenue by Region

   5.10 AMRI

       5.10.1 AMRI Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.10.2 AMRI Pharmaceutical CDMO Product Features

       5.10.3 AMRI Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.10.4 AMRI Pharmaceutical CDMO Revenue by Product Segment

       5.10.5 AMRI Pharmaceutical CDMO Revenue by Region

   5.11 Famar

       5.11.1 Famar Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.11.2 Famar Pharmaceutical CDMO Product Features

       5.11.3 Famar Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.11.4 Famar Pharmaceutical CDMO Revenue by Product Segment

       5.11.5 Famar Pharmaceutical CDMO Revenue by Region

   5.12 WuXi Biologics

       5.12.1 WuXi Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.12.2 WuXi Biologics Pharmaceutical CDMO Product Features

       5.12.3 WuXi Biologics Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.12.4 WuXi Biologics Pharmaceutical CDMO Revenue by Product Segment

       5.12.5 WuXi Biologics Pharmaceutical CDMO Revenue by Region

   5.13 Asymchem

       5.13.1 Asymchem Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.13.2 Asymchem Pharmaceutical CDMO Product Features

       5.13.3 Asymchem Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.13.4 Asymchem Pharmaceutical CDMO Revenue by Product Segment

       5.13.5 Asymchem Pharmaceutical CDMO Revenue by Region

   5.14 Zhejiang Jiuzhou Pharmaceutical

       5.14.1 Zhejiang Jiuzhou Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.14.2 Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Product Features

       5.14.3 Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.14.4 Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Revenue by Product Segment

       5.14.5 Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Revenue by Region

   5.15 Apeloa Pharmaceutical

       5.15.1 Apeloa Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.15.2 Apeloa Pharmaceutical Pharmaceutical CDMO Product Features

       5.15.3 Apeloa Pharmaceutical Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.15.4 Apeloa Pharmaceutical Pharmaceutical CDMO Revenue by Product Segment

       5.15.5 Apeloa Pharmaceutical Pharmaceutical CDMO Revenue by Region

   5.16 Porton Pharma

       5.16.1 Porton Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.16.2 Porton Pharma Pharmaceutical CDMO Product Features

       5.16.3 Porton Pharma Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.16.4 Porton Pharma Pharmaceutical CDMO Revenue by Product Segment

       5.16.5 Porton Pharma Pharmaceutical CDMO Revenue by Region

   5.17 Amatsigroup

       5.17.1 Amatsigroup Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.17.2 Amatsigroup Pharmaceutical CDMO Product Features

       5.17.3 Amatsigroup Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.17.4 Amatsigroup Pharmaceutical CDMO Revenue by Product Segment

       5.17.5 Amatsigroup Pharmaceutical CDMO Revenue by Region

   5.18 Fujifilm Diosynth

       5.18.1 Fujifilm Diosynth Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.18.2 Fujifilm Diosynth Pharmaceutical CDMO Product Features

       5.18.3 Fujifilm Diosynth Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.18.4 Fujifilm Diosynth Pharmaceutical CDMO Revenue by Product Segment

       5.18.5 Fujifilm Diosynth Pharmaceutical CDMO Revenue by Region

   5.19 Biotechnologies

       5.19.1 Biotechnologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.19.2 Biotechnologies Pharmaceutical CDMO Product Features

       5.19.3 Biotechnologies Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.19.4 Biotechnologies Pharmaceutical CDMO Revenue by Product Segment

       5.19.5 Biotechnologies Pharmaceutical CDMO Revenue by Region

   5.20 PCI Pharma Services

       5.20.1 PCI Pharma Services Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.20.2 PCI Pharma Services Pharmaceutical CDMO Product Features

       5.20.3 PCI Pharma Services Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.20.4 PCI Pharma Services Pharmaceutical CDMO Revenue by Product Segment

       5.20.5 PCI Pharma Services Pharmaceutical CDMO Revenue by Region

   5.21 Pfizer CentreOne

       5.21.1 Pfizer CentreOne Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.21.2 Pfizer CentreOne Pharmaceutical CDMO Product Features

       5.21.3 Pfizer CentreOne Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.21.4 Pfizer CentreOne Pharmaceutical CDMO Revenue by Product Segment

       5.21.5 Pfizer CentreOne Pharmaceutical CDMO Revenue by Region

   5.22 Samsung Biologics

       5.22.1 Samsung Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.22.2 Samsung Biologics Pharmaceutical CDMO Product Features

       5.22.3 Samsung Biologics Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.22.4 Samsung Biologics Pharmaceutical CDMO Revenue by Product Segment

       5.22.5 Samsung Biologics Pharmaceutical CDMO Revenue by Region

   5.23 AGC Biologics

       5.23.1 AGC Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.23.2 AGC Biologics Pharmaceutical CDMO Product Features

       5.23.3 AGC Biologics Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.23.4 AGC Biologics Pharmaceutical CDMO Revenue by Product Segment

       5.23.5 AGC Biologics Pharmaceutical CDMO Revenue by Region

   5.24 Divi＇s Laboratories Ltd

       5.24.1 Divi＇s Laboratories Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.24.2 Divi＇s Laboratories Ltd Pharmaceutical CDMO Product Features

       5.24.3 Divi＇s Laboratories Ltd Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.24.4 Divi＇s Laboratories Ltd Pharmaceutical CDMO Revenue by Product Segment

       5.24.5 Divi＇s Laboratories Ltd Pharmaceutical CDMO Revenue by Region

   5.25 Piramal Pharma Solutions

       5.25.1 Piramal Pharma Solutions Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.25.2 Piramal Pharma Solutions Pharmaceutical CDMO Product Features

       5.25.3 Piramal Pharma Solutions Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.25.4 Piramal Pharma Solutions Pharmaceutical CDMO Revenue by Product Segment

       5.25.5 Piramal Pharma Solutions Pharmaceutical CDMO Revenue by Region

   5.26 Syngene International Ltd

       5.26.1 Syngene International Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.26.2 Syngene International Ltd Pharmaceutical CDMO Product Features

       5.26.3 Syngene International Ltd Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.26.4 Syngene International Ltd Pharmaceutical CDMO Revenue by Product Segment

       5.26.5 Syngene International Ltd Pharmaceutical CDMO Revenue by Region

   5.27 Aragen Life Sciences

       5.27.1 Aragen Life Sciences Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.27.2 Aragen Life Sciences Pharmaceutical CDMO Product Features

       5.27.3 Aragen Life Sciences Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.27.4 Aragen Life Sciences Pharmaceutical CDMO Revenue by Product Segment

       5.27.5 Aragen Life Sciences Pharmaceutical CDMO Revenue by Region

   5.28 Akums Drugs and Pharmaceuticals

       5.28.1 Akums Drugs and Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.28.2 Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Product Features

       5.28.3 Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.28.4 Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Revenue by Product Segment

       5.28.5 Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Revenue by Region

   5.29 IDT Australia

       5.29.1 IDT Australia Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.29.2 IDT Australia Pharmaceutical CDMO Product Features

       5.29.3 IDT Australia Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.29.4 IDT Australia Pharmaceutical CDMO Revenue by Product Segment

       5.29.5 IDT Australia Pharmaceutical CDMO Revenue by Region

   5.30 Mayne Pharma

       5.30.1 Mayne Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.30.2 Mayne Pharma Pharmaceutical CDMO Product Features

       5.30.3 Mayne Pharma Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.30.4 Mayne Pharma Pharmaceutical CDMO Revenue by Product Segment

       5.30.5 Mayne Pharma Pharmaceutical CDMO Revenue by Region

   5.31 BioCina

       5.31.1 BioCina Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.31.2 BioCina Pharmaceutical CDMO Product Features

       5.31.3 BioCina Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.31.4 BioCina Pharmaceutical CDMO Revenue by Product Segment

       5.31.5 BioCina Pharmaceutical CDMO Revenue by Region

   5.32 Southern RNA

       5.32.1 Southern RNA Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.32.2 Southern RNA Pharmaceutical CDMO Product Features

       5.32.3 Southern RNA Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.32.4 Southern RNA Pharmaceutical CDMO Revenue by Product Segment

       5.32.5 Southern RNA Pharmaceutical CDMO Revenue by Region

   5.33 PharmSky Research

       5.33.1 PharmSky Research Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.33.2 PharmSky Research Pharmaceutical CDMO Product Features

       5.33.3 PharmSky Research Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)

       5.33.4 PharmSky Research Pharmaceutical CDMO Revenue by Product Segment

       5.33.5 PharmSky Research Pharmaceutical CDMO Revenue by Region

6 Global Pharmaceutical CDMO Market Analysis by Regions, by Product Segment and Application

   6.1 Global Pharmaceutical CDMO Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032

       6.1.1 Global Pharmaceutical CDMO Market Revenue by Region (2020-2025)

       6.1.2 Global Pharmaceutical CDMO Market Revenue Forecast by Region (2026-2032)

   6.2 Global Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   6.3 Global Pharmaceutical CDMO Market Size by Product Application (2020-2032)

7 North America Pharmaceutical CDMO Market Analysis

   7.1 North America Pharmaceutical CDMO Market Prospects

       7.1.1 North America Pharmaceutical CDMO Market Revenue and Growth Forecast by Countries (2020-2032)

       7.1.2 U.S.

       7.1.3 Canada

   7.2 North America Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   7.3 North America Pharmaceutical CDMO Market Size by Product Application (2020-2032)

8 Europe Pharmaceutical CDMO Market Analysis

   8.1 Europe Pharmaceutical CDMO Market Prospects

       8.1.1 Europe Pharmaceutical CDMO Market Revenue and Growth Forecast by Countries (2020-2032)

       8.1.2 Germany

       8.1.3 France

       8.1.4 United Kingdom

       8.1.5 Italy

       8.1.6 Spain

       8.1.7 Benelux

   8.2 Europe Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   8.3 Europe Pharmaceutical CDMO Market Size by Product Application (2020-2032)

9 China Pharmaceutical CDMO Market Analysis

   9.1 China Pharmaceutical CDMO Market Prospects

   9.2 China Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   9.3 China Pharmaceutical CDMO Market Size by Product Application (2020-2032)

10 Asia Pacific (excl. China) Pharmaceutical CDMO Market Analysis

   10.1 Asia Pacific (excl. China) Pharmaceutical CDMO Market Prospects

       10.1.1 Asia Pacific (excl. China) Pharmaceutical CDMO Revenue and Growth Forecast by Countries (2020-2032)

       10.1.2 Japan

       10.1.3 South Korea

       10.1.4 India

       10.1.5 Southeast Asia

       10.1.6 Australia

   10.2 Asia Pacific (excl. China) Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   10.3 Asia Pacific (excl. China) Pharmaceutical CDMO Market Size by Product Application (2020-2032)

11 Latin America Pharmaceutical CDMO Market Analysis

   11.1 Latin America Pharmaceutical CDMO Market Prospects

       11.1.1 Latin America Pharmaceutical CDMO Revenue and Growth Forecast by Countries (2020-2032)

       11.1.2 Mexico

       11.1.3 Brazil

   11.2 Latin America Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   11.3 Latin America Pharmaceutical CDMO Market Size by Product Application (2020-2032)

12 Middle East and Africa Pharmaceutical CDMO Market Analysis

   12.1 Middle East and Africa Pharmaceutical CDMO Market Prospects

       12.1.1 Middle East and Africa Pharmaceutical CDMO Revenue and Growth Forecast by Countries (2020-2032)

       12.1.2 Saudi Arabia

       12.1.3 South Africa

   12.2 Middle East and Africa Pharmaceutical CDMO Market Size by Product Segment (2020-2032)

   12.3 Middle East and Africa Pharmaceutical CDMO Market Size by Product Application (2020-2032)

13 Research Conclusion

14 Appendix

   14.1 Methodology/Research Approach

   14.2 Research Landscape

   14.3 Research Benchmark and Hypothesis

   14.4 Data Source

       14.4.1 Primary Sources

       14.4.2 Secondary Sources

   14.5 Data Cross Validation

   14.6 Disclaimer

image.png

Table 1：Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)

Table 2：Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)

Table 3：Pharmaceutical CDMO Downstream Customers List

Table 4：Pharmaceutical CDMO Distributors/Dealers List

Table 5：Global Pharmaceutical CDMO Market Revenue by Key Players (2021-2025) & (Million USD)

Table 6：Global Pharmaceutical CDMO Market Position by Key Players

Table 7：Global Key Players Headquarter and Key Area Served

Table 8：Global Pharmaceutical CDMO Market Expansion and M&A Dynamic

Table 9：Lonza Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 10：Lonza Pharmaceutical CDMO Product Features

Table 11：Lonza Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 12：Lonza Pharmaceutical CDMO Revenue by Product Segment

Table 13：Lonza Pharmaceutical CDMO Revenue by Region

Table 14：Catalent Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 15：Catalent Pharmaceutical CDMO Product Features

Table 16：Catalent Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 17：Catalent Pharmaceutical CDMO Revenue by Product Segment

Table 18：Catalent Pharmaceutical CDMO Revenue by Region

Table 19：Patheon (Thermo Fisher Scientific) Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 20：Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Product Features

Table 21：Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 22：Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Revenue by Product Segment

Table 23：Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Revenue by Region

Table 24：Aenova Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 25：Aenova Pharmaceutical CDMO Product Features

Table 26：Aenova Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 27：Aenova Pharmaceutical CDMO Revenue by Product Segment

Table 28：Aenova Pharmaceutical CDMO Revenue by Region

Table 29：Siegfried Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 30：Siegfried Pharmaceutical CDMO Product Features

Table 31：Siegfried Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 32：Siegfried Pharmaceutical CDMO Revenue by Product Segment

Table 33：Siegfried Pharmaceutical CDMO Revenue by Region

Table 34：Recipharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 35：Recipharm Pharmaceutical CDMO Product Features

Table 36：Recipharm Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 37：Recipharm Pharmaceutical CDMO Revenue by Product Segment

Table 38：Recipharm Pharmaceutical CDMO Revenue by Region

Table 39：Strides Shasun Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 40：Strides Shasun Pharmaceutical CDMO Product Features

Table 41：Strides Shasun Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 42：Strides Shasun Pharmaceutical CDMO Revenue by Product Segment

Table 43：Strides Shasun Pharmaceutical CDMO Revenue by Region

Table 44：Piramal Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 45：Piramal Pharmaceutical CDMO Product Features

Table 46：Piramal Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 47：Piramal Pharmaceutical CDMO Revenue by Product Segment

Table 48：Piramal Pharmaceutical CDMO Revenue by Region

Table 49：Metrics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 50：Metrics Pharmaceutical CDMO Product Features

Table 51：Metrics Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 52：Metrics Pharmaceutical CDMO Revenue by Product Segment

Table 53：Metrics Pharmaceutical CDMO Revenue by Region

Table 54：AMRI Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 55：AMRI Pharmaceutical CDMO Product Features

Table 56：AMRI Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 57：AMRI Pharmaceutical CDMO Revenue by Product Segment

Table 58：AMRI Pharmaceutical CDMO Revenue by Region

Table 59：Famar Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 60：Famar Pharmaceutical CDMO Product Features

Table 61：Famar Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 62：Famar Pharmaceutical CDMO Revenue by Product Segment

Table 63：Famar Pharmaceutical CDMO Revenue by Region

Table 64：WuXi Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 65：WuXi Biologics Pharmaceutical CDMO Product Features

Table 66：WuXi Biologics Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 67：WuXi Biologics Pharmaceutical CDMO Revenue by Product Segment

Table 68：WuXi Biologics Pharmaceutical CDMO Revenue by Region

Table 69：Asymchem Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 70：Asymchem Pharmaceutical CDMO Product Features

Table 71：Asymchem Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 72：Asymchem Pharmaceutical CDMO Revenue by Product Segment

Table 73：Asymchem Pharmaceutical CDMO Revenue by Region

Table 74：Zhejiang Jiuzhou Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 75：Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Product Features

Table 76：Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 77：Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Revenue by Product Segment

Table 78：Zhejiang Jiuzhou Pharmaceutical Pharmaceutical CDMO Revenue by Region

Table 79：Apeloa Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 80：Apeloa Pharmaceutical Pharmaceutical CDMO Product Features

Table 81：Apeloa Pharmaceutical Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 82：Apeloa Pharmaceutical Pharmaceutical CDMO Revenue by Product Segment

Table 83：Apeloa Pharmaceutical Pharmaceutical CDMO Revenue by Region

Table 84：Porton Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 85：Porton Pharma Pharmaceutical CDMO Product Features

Table 86：Porton Pharma Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 87：Porton Pharma Pharmaceutical CDMO Revenue by Product Segment

Table 88：Porton Pharma Pharmaceutical CDMO Revenue by Region

Table 89：Amatsigroup Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 90：Amatsigroup Pharmaceutical CDMO Product Features

Table 91：Amatsigroup Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 92：Amatsigroup Pharmaceutical CDMO Revenue by Product Segment

Table 93：Amatsigroup Pharmaceutical CDMO Revenue by Region

Table 94：Fujifilm Diosynth Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 95：Fujifilm Diosynth Pharmaceutical CDMO Product Features

Table 96：Fujifilm Diosynth Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 97：Fujifilm Diosynth Pharmaceutical CDMO Revenue by Product Segment

Table 98：Fujifilm Diosynth Pharmaceutical CDMO Revenue by Region

Table 99：Biotechnologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 100：Biotechnologies Pharmaceutical CDMO Product Features

Table 101：Biotechnologies Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 102：Biotechnologies Pharmaceutical CDMO Revenue by Product Segment

Table 103：Biotechnologies Pharmaceutical CDMO Revenue by Region

Table 104：PCI Pharma Services Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 105：PCI Pharma Services Pharmaceutical CDMO Product Features

Table 106：PCI Pharma Services Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 107：PCI Pharma Services Pharmaceutical CDMO Revenue by Product Segment

Table 108：PCI Pharma Services Pharmaceutical CDMO Revenue by Region

Table 109：Pfizer CentreOne Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 110：Pfizer CentreOne Pharmaceutical CDMO Product Features

Table 111：Pfizer CentreOne Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 112：Pfizer CentreOne Pharmaceutical CDMO Revenue by Product Segment

Table 113：Pfizer CentreOne Pharmaceutical CDMO Revenue by Region

Table 114：Samsung Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 115：Samsung Biologics Pharmaceutical CDMO Product Features

Table 116：Samsung Biologics Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 117：Samsung Biologics Pharmaceutical CDMO Revenue by Product Segment

Table 118：Samsung Biologics Pharmaceutical CDMO Revenue by Region

Table 119：AGC Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 120：AGC Biologics Pharmaceutical CDMO Product Features

Table 121：AGC Biologics Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 122：AGC Biologics Pharmaceutical CDMO Revenue by Product Segment

Table 123：AGC Biologics Pharmaceutical CDMO Revenue by Region

Table 124：Divi＇s Laboratories Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 125：Divi＇s Laboratories Ltd Pharmaceutical CDMO Product Features

Table 126：Divi＇s Laboratories Ltd Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 127：Divi＇s Laboratories Ltd Pharmaceutical CDMO Revenue by Product Segment

Table 128：Divi＇s Laboratories Ltd Pharmaceutical CDMO Revenue by Region

Table 129：Piramal Pharma Solutions Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 130：Piramal Pharma Solutions Pharmaceutical CDMO Product Features

Table 131：Piramal Pharma Solutions Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 132：Piramal Pharma Solutions Pharmaceutical CDMO Revenue by Product Segment

Table 133：Piramal Pharma Solutions Pharmaceutical CDMO Revenue by Region

Table 134：Syngene International Ltd Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 135：Syngene International Ltd Pharmaceutical CDMO Product Features

Table 136：Syngene International Ltd Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 137：Syngene International Ltd Pharmaceutical CDMO Revenue by Product Segment

Table 138：Syngene International Ltd Pharmaceutical CDMO Revenue by Region

Table 139：Aragen Life Sciences Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 140：Aragen Life Sciences Pharmaceutical CDMO Product Features

Table 141：Aragen Life Sciences Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 142：Aragen Life Sciences Pharmaceutical CDMO Revenue by Product Segment

Table 143：Aragen Life Sciences Pharmaceutical CDMO Revenue by Region

Table 144：Akums Drugs and Pharmaceuticals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 145：Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Product Features

Table 146：Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 147：Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Revenue by Product Segment

Table 148：Akums Drugs and Pharmaceuticals Pharmaceutical CDMO Revenue by Region

Table 149：IDT Australia Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 150：IDT Australia Pharmaceutical CDMO Product Features

Table 151：IDT Australia Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 152：IDT Australia Pharmaceutical CDMO Revenue by Product Segment

Table 153：IDT Australia Pharmaceutical CDMO Revenue by Region

Table 154：Mayne Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 155：Mayne Pharma Pharmaceutical CDMO Product Features

Table 156：Mayne Pharma Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 157：Mayne Pharma Pharmaceutical CDMO Revenue by Product Segment

Table 158：Mayne Pharma Pharmaceutical CDMO Revenue by Region

Table 159：BioCina Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 160：BioCina Pharmaceutical CDMO Product Features

Table 161：BioCina Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 162：BioCina Pharmaceutical CDMO Revenue by Product Segment

Table 163：BioCina Pharmaceutical CDMO Revenue by Region

Table 164：Southern RNA Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 165：Southern RNA Pharmaceutical CDMO Product Features

Table 166：Southern RNA Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 167：Southern RNA Pharmaceutical CDMO Revenue by Product Segment

Table 168：Southern RNA Pharmaceutical CDMO Revenue by Region

Table 169：PharmSky Research Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 170：PharmSky Research Pharmaceutical CDMO Product Features

Table 171：PharmSky Research Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)

Table 172：PharmSky Research Pharmaceutical CDMO Revenue by Product Segment

Table 173：PharmSky Research Pharmaceutical CDMO Revenue by Region

Table 174：Global Pharmaceutical CDMO Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)

Table 175：Global Pharmaceutical CDMO Market Revenue by Region (2020-2025) & (Million USD)

Table 176：Global Pharmaceutical CDMO Market Share by Region (2020-2025)

Table 177：Global Pharmaceutical CDMO Market Revenue Forecast by Region (2026-2032) & (Million USD)

Table 178：Global Pharmaceutical CDMO Market Share Forecast by Region (2026-2032)

Table 179：Global Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 180：Global Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 181：Global Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 182：Global Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 183：North America Pharmaceutical CDMO Market Revenue by Countries (2020-2025) & (Million USD)

Table 184：North AmericaPharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 185：North America Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 186：North America Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 187：North America Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 188：North America Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 189：Europe Pharmaceutical CDMO Market Revenue by Countries (2020-2025) & (Million USD)

Table 190：Europe Pharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 191：Europe Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 192：Europe Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 193：Europe Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 194：Europe Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 195：China Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 196：China Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 197：China Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 198：China Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 199：Asia Pacific (excl. China) Pharmaceutical CDMO Market Revenue by Countries (2020-2025) & (Million USD)

Table 200：Asia Pacific (excl. China) Pharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 201：Asia Pacific (excl. China) Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 202：Asia Pacific (excl. China) Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 203：Asia Pacific (excl. China) Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 204：Asia Pacific (excl. China) Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 205：Latin America Pharmaceutical CDMO Market Revenue by Countries (2020-2025) & (Million USD)

Table 206：Latin America Pharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 207：Latin America Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 208：Latin America Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 209：Latin America Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 210：Latin America Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 211：Middle East and Africa Pharmaceutical CDMO Market Revenue by Countries (2020-2025) & (Million USD)

Table 212：Middle East and Africa Pharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 213：Middle East and Africa Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 214：Middle East and Africa Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 215：Middle East and Africa Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)

Table 216：Middle East and Africa Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 217：Secondary Sources


image.png

Figure 1：Pharmaceutical CDMO Product Scope

Figure 2：Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)

Figure 3：Global Pharmaceutical CDMO Product Segment Market Share (2025 & 2032)

Figure 4：Global Pharmaceutical CDMO Product Application Market Share (2025 & 2032)

Figure 5：Solid Formulation Product Scope

Figure 6：Semi-solid Formulation Product Scope

Figure 7：Liquid Formulation Product Scope

Figure 8：Gas Formulation Product Scope

Figure 9：Chemical Pharmaceutical Product Scope

Figure 10：Biopharmaceutical Product Scope

Figure 11：Others Product Scope

Figure 12：Pharmaceutical CDMO Industrial Chain Framework

Figure 13：Global Pharmaceutical CDMO Market by Geographic Segmentation in 2025

Figure 14：Global Pharmaceutical CDMO Market Share by Region (2020 VS 2025)

Figure 15：North America Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 16：North America Pharmaceutical CDMO Revenue Market Share by Countries (2025 VS 2032)

Figure 17：U.S. Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 18：Canada Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 19：Europe Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 20：Europe Pharmaceutical CDMO Revenue Market Share by Countries (2025 VS 2032)

Figure 21：Germany Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 22：France Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 23：United Kingdom Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 24：Italy Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 25：Spain Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 26：Benelux Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 27：China Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 28：Asia Pacific (excl. China) Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 29：Asia Pacific (excl. China) Pharmaceutical CDMO Revenue Market Share by Countries (2025 VS 2032)

Figure 30：Japan Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 31：South Korea Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 32：India Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 33：Southeast Asia Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 34：Australia Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 35：Latin America Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 36：Latin America Pharmaceutical CDMO Revenue Market Share by Countries (2025 VS 2032)

Figure 37：Mexico Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 38：Brazil Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 39：Middle East and Africa Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 40：Middle East and Africa Pharmaceutical CDMO Revenue Market Share by Countries (2025 VS 2032)

Figure 41：Saudi Arabia Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 42：South Africa Pharmaceutical CDMO Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 43：Research Methodology

Figure 44：Primary Sources

Figure 45：Data Cross Validation

Global Pharmaceutical CDMO Revenue and Market Share by Key Players

Revenue (US$ Million)20202021202220232024
LonzaXXXXXXXXXX
CatalentXXXXXXXXXX
Patheon (Thermo Fisher Scientific)XXXXXXXXXX
AenovaXXXXXXXXXX
SiegfriedXXXXXXXXXX
RecipharmXXXXXXXXXX
Strides ShasunXXXXXXXXXX
PiramalXXXXXXXXXX
MetricsXXXXXXXXXX
AMRIXXXXXXXXXX
FamarXXXXXXXXXX
WuXi BiologicsXXXXXXXXXX
AsymchemXXXXXXXXXX
Zhejiang Jiuzhou PharmaceuticalXXXXXXXXXX
Apeloa PharmaceuticalXXXXXXXXXX
Porton PharmaXXXXXXXXXX
AmatsigroupXXXXXXXXXX
Fujifilm DiosynthXXXXXXXXXX
BiotechnologiesXXXXXXXXXX
PCI Pharma ServicesXXXXXXXXXX
Pfizer CentreOneXXXXXXXXXX
Samsung BiologicsXXXXXXXXXX
AGC BiologicsXXXXXXXXXX
Divi＇s Laboratories LtdXXXXXXXXXX
Piramal Pharma SolutionsXXXXXXXXXX
Syngene International LtdXXXXXXXXXX
Aragen Life SciencesXXXXXXXXXX
Akums Drugs and PharmaceuticalsXXXXXXXXXX
IDT AustraliaXXXXXXXXXX
Mayne PharmaXXXXXXXXXX
BioCinaXXXXXXXXXX
Southern RNAXXXXXXXXXX
PharmSky ResearchXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png

Related Reports
Global Healthcare Supply Chain Managements Market Competitors, Segment Types and Downstream Applications Research Report 2025
2025-04-10
Global Healthcare Supply Chain Managements Market Size, Competition Landscape and Supply Chain Research Report 2025
2025-04-10
Global Hemodialysis and Peritoneal Dialysis Market Competitors, Segment Types and Downstream Applications Research Report 2025
2025-04-10
Global Hemodialysis and Peritoneal Dialysis Market Size, Competition Landscape and Supply Chain Research Report 2025
2025-04-10
Global Pharmaceutical CDMO Market Competitors, Segment Types and Downstream Applications Research Report 2025
2025-04-10
Global Full-Service Clinical Research Organization (CRO) Market Competitors, Segment Types and Downstream Applications Research Report 2025
2025-04-10
Global Full-Service Clinical Research Organization (CRO) Market Size, Competition Landscape and Supply Chain Research Report 2025
2025-04-10
Global Glycomics/Glycobiology Market Competitors, Segment Types and Downstream Applications Research Report 2025
2025-04-10
How to Order
Contact
Fill in your contact information, and the company will quickly match the specialist to get in touch with you
You can also directly call our customer service hotline or add customer service WeChat
Samples
One on one business specialist will send the complete version of the sample
If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
Both parties sign a report purchase contract
Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
PDF report (sent online 2-3 working days after payment)
WORD version report (sent online 2-3 working days after payment)
Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
No Relevant Report Found? Please Contact Us
Custom Reports
WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.
About WENKH
Home
Reports
Custom Research
Industry News
About Us
Contact
Contact Us
Ocean Tower, No.145, Hong Kong Road, Wuhan City, Hube Province, China
Copyright © WENKH.com All rights reserved.